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Exercise has been widely believed to be a preventive and therapeutic aid in the treatment of various
pathophysiological conditions such as cardiovascular disease and cancer. A common problem associ-
ated with such pathologies is cachexia, characterized by progressive weight loss and depletion of lean
and fat body mass, and is linked to poor prognosis. As this syndrome comprises changes in many
physiological systems, it is tempting to assume that the modulation of the psychoneuroimmunoendo-
crine axis could attenuate or even prevent cachexia progression in cancer patients. Cancer cachexia is
characterized by a disruption in the rhythmic secretion of melatonin, an important time-conditioning
effector. This hormone, secreted by the pineal gland, transmits circadian and seasonal information to
all organs and cells of the body, synchronizing the organism with the photoperiod. Considering that
exercise modulates the immune response through at least two different mechanisms—metabolic and
neuroendocrine—we propose that the adoption of a regular exercise program as a complementary
strategy in the treatment of cancer patients, with the exercise bouts regularly performed at the same
time of the day, will ameliorate cachexia symptoms and increase survival and quality of life.
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Introduction
In many chronic diseases, such as cancer and chronic heart
failure, patients die as a direct consequence of cachexia, a
profound metabolic process characterized by the breakdown
of skeletal muscle and deleterious, chaotic abnormalities in
fat and carbohydrate metabolism (1). This syndrome is
accompanied by changes in the neuroimmunoendocrine axis,
as reviewed by Langstein and Norton (2) and Langhans (3).
Physical exercise is one of the strategies adopted to counter-
act protein wasting during chronic diseases (4). In addition to
the positive impact of exercise on protein metabolism, we
propose that exercise acts as a ‘time-conditioning effector’
which regulates the neuroimmunoendocrine axis, increases
survival and improves quality of life.
Exercise or regular physical activity has been widely
adopted as a preventive or therapeutic aid in the treatment of
numerous physiopathological conditions, including cardio-
vascular diseases (5) and some aspects of senescence (6). The
immense potential of exercise in various conditions seems to
be correlated to the fact that it promotes adaptations in all
the systems of the organism. This concept about the benefi-
cial effects of exercise on human health is quite recent. In the
past, physicians traditionally advised patients with chronic
diseases, such as cardiovascular disorders, to avoid physical
activity. However, the investigation of cardiac rehabilitation
in the 1960s showed the benefits of early mobilization after
myocardial infarction, which led to the development of car-
diac rehabilitation programs based on exercise (7–9). In fact,
these studies served as a starting point for research on the
effects of exercise on other systems and pathophysiological
processes such as immune response, cancer and inflamma-
tion.
As evidence supporting cardiac rehabilitation programs is
available, we have started developing a scientific basis for the
use of exercise as an adjuvant therapy for cancer patients. In
fact, exercise has been used to improve shoulder mobility
after breast cancer surgery (10), to help maintain the energy
balance during adjuvant chemotherapy (4,11) and to improve
the quality of life of cancer survivors (12,13). Leung et al.
(14) showed that serum obtained from patients who had
undergone exercise programs had reduced LNCaP prostate64 Exercise and neuroimmunoendocrine system
cancer cell growth by 27%, through an increase in cellular
p53 protein content. Despite these emerging results, the
present exercise programs are neither well defined nor
included in the list of possible interventions for management
of cancer symptoms.
Exercise and the Immune System
During the last two decades, a great effort has been made to
understand the mechanisms that underlie the relationship
between exercise and the immune system, as a second step in
the study of the effects of physical activity on health. In fact,
physical fatigue, caused by exercise or manual work, has long
been considered a factor affecting susceptibility to illness. A
study carried out in the earlier part of the previous century
linked physical fatigue with increased susceptibility to polio-
myelitis (15). Several studies provide epidemiological evi-
dence that supports the anecdotal belief that regular exercise
increases resistance to infections such as common cold
whereas intense training is associated with increased upper
respiratory tract infections (16–18). The positive effect of
exercise on other diseases has also been acknowledged, and
there is increasing evidence that physical activity, as a life-
style, offers protection against malignancy (19).
This dual effect of exercise on the immune system led a
group of scientists (20) to postulate a J-shaped curve to
better express this relationship. Their results indicate that
moderate intensity exercise lowers the incidence of infections
while intense exercise increases it. Therefore, the present
study aids to investigate the underlying mechanisms of such a
relationship. Two principal research approaches have emerged
in trying to establish a link between exercise and the immune
system—a metabolic approach that involves glutamine
metabolism (21), and another that considers changes in the
neuroendocrine milieu as the mechanism for immunomodu-
lation (22).
Glutamine Hypothesis
Glutamine is a ‘conditionally essential’ amino acid, which
comprises 20% of the total plasma amino acids, and is
actively produced in different organs—liver, kidneys, lungs
and skeletal muscle (23)—under different pathophysiological
conditions. Skeletal muscle is a major glutamine producer,
and can release the amino acid into the bloodstream at a high
rate (24,25). During the 1980s, Professor Eric Newsholme, at
the University of Oxford, demonstrated that rapidly dividing
cells, such as lymphocytes, as well as macrophages, both
immune cells possessing a high secretory activity, utilize high
rates of glutamine even when quiescent (26–28). It was also
demonstrated that the glutamine pathway in both cell types is
under external regulation, partly because of the supply of
glutamine itself (26,27,29). Glutamine, when supplied to the
immune cells in the proper concentration (30,31), allows
lymphocytes to proliferate, killer cells to respond to lym-
phokines, and immune cells to produce cytokines. It also reg-
ulates macrophage function. The demand of the skeletal
muscle and other organs for glutamine during intense
exhaustive exercise, or after surgery, trauma, burns and
sepsis, is such that the immune system may be forced into
a glutamine debt, which temporarily affects its function (32–
34).
Poortmans et al. (35) and Decombaz et al. (36) reported
that a biphasic response of plasma glutamine concentration
is present during exercise. A short-term exercise results in an
increase in plasma glutamine concentration (27,35,37), while
its concentration may decrease by as much as 25%, after a
full marathon (21). Rennie et al. (38) demonstrated that ath-
letes who ran on a treadmill at 50% of the maximal oxygen
uptake  showed  increased  glutaminemia  during  the  first
three hours of running, followed by a 17% decrease below
pre-exercise levels after 3.75 h. This reduction in plasma
glutamine concentration was also observed in overtrained
athletes, who showed an unexplained decreased performance
associated with higher incidence of upper respiratory tract
infections (39,40).
Castell et al., who studied more than 350 runners, reported
that plasma glutamine concentration also falls after a mara-
thon. They observed a 15% decrease in the amino acid
concentration, 15 min after the end of the race, and an
additional 15% decrease within the next hours, from 669 to
533 µmol/l (21). The magnitude and the duration of lowered
plasma glutamine vary considerably with the type of sport
studied and the intensity of the exercise bout. Walsh et al.
(41) observed a reduction in plasma amino acid concentra-
tion 5 h after an exhaustive cycling protocol while Rhodes et
al. recorded the same observation in triathletes, 2 h after pro-
longed exercise. In our laboratory we found a reduction of
25% in plasma glutamine concentration after an Olympic
triathlon, in well-trained, top-ranking athletes (42). A similar
change was observed in athletes after 12 bouts of a 20-min
cycling protocol (20-min rest period between two bouts) at
95% of the maximum oxygen uptake (43). It is interesting to
note that the group that received carbohydrate supplementa-
tion, in the latter experiment, did not show any change in
plasma glutamine concentration (43). The same observation
was recorded by Lehman et al. (44) and Castell (29) after
ultramarathons, during which the runners stopped routinely
for 15 min and ingested food and drinks ad libitum.
The decrease observed in glutaminemia correlates with
increased symptoms of upper respiratory tract infections
(21,42), suggesting that immunodepression may occur in
some athletes due to stress induced by prolonged, exhaustive
exercise and competition. Some of the factors that might
render athletes more vulnerable to opportunistic viruses or
bacterial agents, as proposed by Castell (21), are a higher
training mileage, additional stress (the mental stress of com-
petition more than doubled the risk of getting an upper respi-
ratory tract infection), a low body mass, bypassing the nasal
filter mechanism (during exercise, athletes breathe through
the mouth rather than through the nose, impairing the pro-eCAM 2004;1(1) 65
tective effects of mucosal secretions) and a decrease in envi-
ronmental temperature.
Immune Changes after Exercise
The most common changes in immune cell function after
strenuous exercise comprise decreased neutrophil activity,
impaired antibody synthesis, decreased immunoglobulin lev-
els in blood and saliva, decreased cytolytic activity of natural
killer (NK) cells, lower circulating T lymphocyte number for
3–4 h after exercise, a reduction in the proliferative ability of
lymphocytes in response to mitogens, and profound changes
in the profile of cytokines produced after exercise, including a
100-fold increase in interleukin-6 production, and an aug-
mented production of anti-inflammatory mediators (21,22).
These changes are transient, and most of them return to
the basal level a few hours after exercise. In general, however,
there are some long-term changes in the immune response of
athletes. The adaptive immune system (resting state) seems
to be largely unaffected by intensive and prolonged exercise
training (45,46). The innate immune system appears to
respond differently to the chronic stress of intensive exercise,
with NK cell activity tending to be enhanced while neutrophil
function is suppressed (47–50). However, the clinical signifi-
cance of such changes remains to be elucidated.
How to Deal with Changes in Plasma 
Glutamine?
While considering the glutamine hypothesis, it is quite tempt-
ing to speculate that maintaining the plasma glutamine con-
centration within the normal range (found at rest) will restore
the immune changes observed after strenuous exercise.
Castell et al. (51,52) supplemented athletes with 7 or 5 g of
glutamine per day and found only a slight and transient
increase in plasma amino acid levels, which was, nevertheless,
enough to decrease the incidence of upper respiratory tract
infections (URTI) (53) as well as to prevent the changes in the
CD4 : CD8 ratio found in the athletes of the placebo group
(52). Our own studies (42) showed a similar magnitude of
decrease in the incidence of infections in triathletes, in a
group of athletes supplemented for 1 month with branched
chain amino acids—precursors for glutamine synthesis. The
supplementation protocol was efficient in maintaining the
plasma glutamine levels after an Olympic triathlon within the
same range as that found at rest. The maintenance of plasma
glutamine levels was paralleled by an augmented production
of IL-1, IL-2, tumor necrosis factor α (TNF-α), and inter-
feron γ (IFN-γ), with changes in the balance between Th1:
Th2 type immune response. Another study on athletes
reported a reduction in IL-4 production in the supplemented
group after a 30-km run (54), reinforcing the potential
change in the type of immune response presented by the ath-
letes who received branched chain amino acids as precursors
for glutamine synthesis, and its diversion towards a Th1 type
response, which promotes cellular immunity (55).
Therefore, it may be possible that the supplementation of
glutamine or branched chain amino acids to athletes engaged
in long-distance high-intensity exhaustive exercise might
increase glutamine availability for the immune system at a
critical period when athletes are vulnerable to opportunistic
infections. On the other hand, moderate intensity exercise
will warrant constant plasma glutamine concentration, which
could be beneficial to the integrity of the immune response
during wasting conditions such as cancer cachexia.
The ‘Open Window’ Hypothesis
The second hypothesis that attempts to explain the relation-
ship between exercise and the immune system is based on the
changes observed in the neuroendocrine system, and is
known as the ‘open window’ hypothesis (22). During exer-
cise, there is a marked increase in the plasma levels of
adrenaline, noradrenaline, growth hormone and cortisol.
Depending on the exercise intensity and duration, the profile
of secretion of these hormones and their clearance rates are
substantially modified (22,56). Adrenaline, and to a lesser
degree noradrenaline, seem to be responsible for the acute
effects of exercise on lymphocyte dynamics and lymphocyte
function (57) and NK cell activity (22). Increase in growth
hormone and catecholamine levels mediates the acute effects
on neutrophils whereas cortisol exerts its effects within a time
lag of at least 2 h, depending on the exercise duration and
intensity, and therefore may help to maintain lymphopenia
and neutrocytosis only after long-term exercise (18,58). The
role of β-endorphins is less clear, but possibly linked to the
immediate recruitment of NK cells in the blood (22).
As shown by several authors (43,54,59), exhaustive exercise
induces a drift towards a Th1 type immune response associ-
ated with the production of glucocorticoids. Considering that
glucocorticoids suppress the production of TNF-α, IFN-γ
and IL-2 (60,61), which are important regulators of the Th1
type immune response, and that humoral immunity decreases
during exhaustion, we can accept this as an important
mechanism to explain exercise-induced immunodepression.
Another interesting aspect is the effect of catecholamines in
shifting the immune response towards a Th2-mediated
humoral immunity. This effect could counteract the immuno-
depression related to exhaustion immediately after an acute
bout of exercise, thereby maintaining the homeostasis of the
immune response in such conditions. In fact, this could be
linked to the ‘stress–immune paradox’ (62). Dhabbar et al.
observed an enhancement in delayed type hypersensitivity
response after acute stress. However, their studies demon-
strated that the immune response should be enhanced, and
not depressed, to protect the host during acute physical
and/or psychological stress (62–64). If the physical exercise
or psychological stress is above the adaptive capacity of the
organism, over a long period of time, the effect will be delete-
rious (62,65).
The ‘stress-immune paradox’ could be correlated with
the ‘Cognitive Activation Theory of Stress’, postulated by66 Exercise and neuroimmunoendocrine system
Eriksen et al. (66) as a reformulation of the stress theory,
within a homeostatic and physiological framework. Accord-
ing to this theory, the phases of the response are interpreted
as an alarm occurring within a complex cognitive network,
with feedback and control loops. One important consequence
of this approach, at least for the model that correlates
immunological changes and exercise through a neuroendo-
crine mechanism, is that the response is dynamic and
develops over time. This time element must be taken into
account as the stress response develops in phases. A better
understanding of these phases is crucial to predict the patho-
physiological consequences of the relationships between
the stressor and the observed physiological response. As
postulated by Eriksen et al. (66), subjects with efficient coping
show the fast- and short-lasting catecholamines response while
subjects with high defense mechanisms (related to stimulus
expectancies) may show more signs of prolonged activation.
Non-coping individuals show a sustained general activation,
which may develop into somatic disease or illness.
Therefore, many metabolic and hormonal changes
observed during cachexia could be counteracted by those
induced by regular exercise, known to promote changes that
can be sustained for more than 24 h in the hormonal profile
of athletes and also to positively modulate the immune
response.
Integrating the Systems: 
a Psychoneuroimmunoendocrine System
Based on previous studies (67–70), we can hypothesize the
existence of a neuroimmunoendocrine system that communi-
cates through peptides, monoamines, glucocorticoids, free
radicals, cytokines and opioids. Furthermore, neuropeptides
found in the central nervous system, which show several
immunomodulatory properties, are also expressed by
immune cells (71,72). Another interesting point that rein-
forces the existence of such an integrative axis is the presence
of ‘receptors’ of various neurohormones and hypothalamic
releasing factors in leukocytes (67,68,70,73,74). Many
authors, on the other hand, have postulated the existence of
a psychoneuroimmunologic axis that (69,75) integrates the
central nervous system, behavior and the immune system. As
the nervous and the immune system actively interact with
the endocrine system, we can acknowledge a psychoneuro-
Figure 1. Interconnections among the nervous, immune, endocrine and muscular systems. These interactions involve the actions of small molecules such as
neuropeptides and cytokines, hormone secretion, nervous activation and opioid peptides. ACTH, adrenocorticotropin hormone; CRH, corticotropin releasing
hormone; E, estrogen; T, testosterone; TSH, thyroid-stimulating hormone; GH, growth hormone; IL-6, interleukin 6; LH, luteinizing hormone; LHRH,
luteinizing hormone-releasing hormone.eCAM 2004;1(1) 67
immunoendocrine system. This system is the key to under-
standing various mechanisms, which are still primarily a
patchwork of loosely linked observations, and thereby provide
novel but fundamentally unsubstantiated treatments for dis-
orders such as cancer, as proposed by Schleifer (75).
In the early 1980s, traditional immunologists and other sci-
entists and physicians reviewed the proposal of this integra-
tive system as an attempt to legitimize alternative medicine,
and maintained that there was no correlation between
psychosocial factors and survival in cancer patients (76,77).
However, over the last decade, evidence showing that psycho-
logical stress modulates the immune system has been accu-
mulated. In fact, it seems that chronic stress, such as marital
problems, work-related stress or bereavement, has a suppres-
sive effect on the parameters of immune response (69),
including a reduction in the number of T and B lymphocytes,
decreased proliferative response to mitogens and decreased
NK activity, leading to increased susceptibility to infections
and worsening of existing diseases such as cancer. On the
other hand, it seems that acute stress, such as examination
stress or experimentally induced stress, has a positive impact
on immune parameters (69,78–82).
Considering the information presented in the previous par-
agraph, it seems quite impossible to avoid changing the terms
‘chronic stress’ and ‘acute stress’ to ‘chronic exhaustive exer-
cise’ and ‘acute exercise’. The assumption that exercise may
be acting on a psychoneuroimmunoendocrine system opens
multiple possibilities of using exercise as a therapy: prevent-
ing and/or reducing the incidence of chronic diseases, acting
as a coadjuvant in the treatment of Alzheimer’s disease (83),
sub-acute low back pain (84), rheumatoid arthritis (85),
fibromyalgia syndrome (86), cancer (87), chronic heart fail-
ure (88) and HIV-associated depression (89), among others.
Therefore, considering that an organism functions in an
integrative manner, we can accept the proposal made by Pro-
fessor Newsholme and integrate the skeletal muscle in our
psychoneuroimmunoendocrine axis (Fig. 1) because gluta-
mine seems to be essential for immune cells and its synthesis
is controlled by hormones (90). In fact, when investigating
the relationship between glutamine and the immune system
during exercise, we tested the immune response of athletes
subjected to 12 bouts of indoor cycling, 20 min each, with 20
min interval, at 95% of the maximal oxygen consumption.
We observed that the athletes who received carbohydrate
supplementation during the trial showed a blunted response
of cortisol during exercise and were able to maintain plasma
glutamine levels within the normal range (43). After exercise,
the proliferative response of lymphocytes to mitogens as well
as the production of IL-1, IL-2, IL-4 and TNF-α were restored
to the pre-exercise levels, indicating that both hypotheses—
glutamine and ‘open window’—cannot be excluded.
Exercise as a ‘Zeitgeber’
In the past few years, the studies carried out in our laboratory
provided evidence that led us to evaluate the possible effect
of exercise as a ‘Zeitgeber’ or a time-conditioning effector. In
mammals, the pineal gland transduces photoperiodic infor-
mation to the neuroendocrine axis through nocturnal mela-
tonin secretion (91). This hormonal message plays a key role
in the biorhythm regulation, acting as a ‘Zeitgeber’, adjusting
the internal clock to a 24-h cycle based on dark and light
periods (91,92). Cachexia is a metabolic syndrome that
occurs in about 80% of all advanced cancer patients and is
associated with a decreased survival time (93,94). It is defined
as ‘a wasting syndrome involving loss of muscle and fat
directly caused by tumor factors or indirectly caused by an
aberrant host response to tumor presence’, characterized by
breakdown of skeletal muscle and harmful, chaotic abnor-
malities in fat and carbohydrate metabolism, despite ade-
quate nutritional intake (1,95,96). These changes in energy
metabolism are mediated by factors such as cytokines, sero-
tonin, lactate, ketone bodies, glucocorticoids and thyroid
hormones (97,98). The net metabolic result is increased basal
energy expenditure that reflects a global change in energy
use, associated with wasting of energy reserves combined
with anorexia, which significantly reduces caloric intake (99).
Considering that melatonin transmits circadian and seasonal
information to all organs and cells of the body, thereby
synchronizing the physiological processes and metabolism
including energy metabolism (100) with the daily and annual
photoperiod variations, it seems quite reasonable to assume
that changes in its profile would lead to a loss of metabolic
control that facilitates the initiation of cachexia-related
changes. In fact, Bartsch et al. (101) showed a tumor-depend-
ent depression of serum melatonin in patients with prostate
or breast cancer. However, according to Bartsch and Bartsch
(102) it is unclear whether the plasma melatonin depletion in
cancer patients is due to peripheral metabolic processes or a
reduced production by the pineal gland. Therefore, consider-
ing the possible link between melatonin and cancer cachexia,
we showed that the administration of a daily dose of mela-
tonin to Walker-256 tumor-bearing rats extended the life
span of the animals by approximately 100% (103). This
Figure 2. Life span of Walker-256 tumor-bearing rats trained for 8 weeks, 5
days a week, 3 h after the beginning of the dark period, at 60% maximum
oxygen consumption (RegT), and that of tumor-bearing rats that followed
the same training protocol, but exercised randomly throughout the day
(RanT), compared with that showed by sedentary tumor-bearing animals
(Sed). There were 25 animals/group, and the protocol described by Bacurau
et al. (107) was followed. *P <0.05 for comparison with Sed group.68 Exercise and neuroimmunoendocrine system
result indicates that the rhythm of melatonin or its produc-
tion may be impaired in our model, as previously described
for other types of cancer (101,104).
To better understand what happens to melatonin rhythm
during cachexia, we determined the 24-h profile of melatonin
production in tumor-bearing rats during cachexia develop-
ment. Ferreira et al. (105) showed that during Walker-256
tumor progression, the animals showed profound changes in
the profile of melatonin secretion, with changes in the secre-
tory profile of the amine as well as in the total amount of its
secretion and in the response of the pineal gland to noradren-
aline stimulation. It is interesting to note that the total
amount of melatonin produced increased during cancer
cachexia, but the profile of production during the dark period
was profoundly changed. In fact, we observed a dramatic
alteration on day 7 after tumor implantation, when the first
signs of cachexia could be observed in the tumor-bearing rats
(106). We also detected the highest melatonin production on
day 7. On the day 14, the melatonin secretory profile was dif-
ferent from that observed in control rats, but the total
amount of melatonin secreted during the night decreased.
The change in the total amount and in the profile of mela-
tonin production by the pineal gland of tumor-bearing rats
could be involved in cancer cachexia progression, leading to a
disruption in metabolism.
We also demonstrated that a regular exercise program pro-
longs the life span of Walker-256 tumor-bearing rats (107).
The animals were trained for 1 h every day, starting always at
the same hour during the dark period. Interestingly, we found
that the moderate intensity protocol (60% maximal oxygen
uptake) and the high-intensity protocol (85% maximal oxy-
gen uptake) provoked the same effect, increasing the rats’ life
span if the training sessions were carried out at the same hour
during the day. If the daily exercise bout was performed ran-
domly through the day, the increase in life span was abolished
(Fig. 2). Therefore, it seems quite reasonable to assume that
a possible mechanism to explain the effects of exercise upon
cancer cachexia could be related to its ability to act as a
‘time-conditioning effector’, assuming the previous function
of melatonin. In fact, Baehr et al. (108) showed that exercise
can phase-shift the circadian rhythms of young adults if per-
formed at the right time of the day. The literature provides
evidence of many other time markers that may partially
replace melatonin in entraining the organism, such as food-
anticipatory activity (109), exogenous corticosteroids (110)
or even a carbohydrate-rich meal (111). On the other hand, a
loss in melatonin secretory pattern is observed during ageing
(112) and some pathologies such as chronic fatigue syndrome
(113), in which the prescription of a regular training program
restores the sleep pattern and general feeling of wellness
(6,113). The potential role of exercise as a time-conditioning
effector in different pathophysiological conditions needs to
be further evaluated. The fact that a regular exercise program
could postpone cell death by cancer cachexia assumes even
more importance if we consider the premise of Zajicek (114)
that the treatment of cancer patients is based on the false
premise that the tumor is the only threat to the patient. Thus,
exercise would be an important complementary and alterna-
tive strategy for the treatment of cachexia.
Therefore, taking into account that physical exercise
affects all tissues and systems in the human body, interacting
and modulating the psychoneuroimmunoendocrine system,
that changes in the equilibrium of such a system during
chronic diseases such as cancer and chronic heart failure lead
to cachexia, and that during cachexia there is a loss of control
of the internal rhythm through rhythmic melatonin produc-
tion by the pineal gland, it seems that a regular exercise pro-
gram could be a useful and low-cost intervention to reduce
cachexia-related mortality as well as serving as a complemen-
tary strategy for improving the quality of life of cancer survi-
vors and reducing costs of the public health system.
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